Caffeic Acid Inhibits Swelling, Bone Loss, and Osteoclastogenesis in Adjuvant-induced Arthritis Rats

Ferry Sandra, Muhammad Ihsan Rizal, Nurrani Mustika Dewi, Toshio Kukita

Abstract


BACKGROUND: Increase in inflammatory cytokine levels promotes pathological osteoclast differentiation. Caffeic acid has anti-inflammatory properties and can inhibit osteoclast bone resorption. In vitro studies have reported the ability of caffeic acid in inhibiting osteoclastogenesis pathways, however the in vivo study is rarely conducted. The aim of this study is to examine the role of caffeic acid in reducing inflammation and inhibiting osteoclastogenesis in Adjuvant-Induced Arthritis (AIA) rats.

METHODS: Rats were injected with Freund’s Complete Adjuvant (CFA) and mineral oil. One day after injection, various concentration (0, 5, 25, 125 mg) of caffeic acid were given gastro-intestinally. Swelling degree in rats’ ankle joints was determined by measuring height and width of each ankle joint. Bone loss level was examined with soft X-ray, and then bone density was calculated. To examine osteoclastogenesis, ankle joints were stained with Tartrate-Resistant Acid Phosphatase (TRAP) and evaluated microscopically.

RESULTS: Ankle joints of AIA rats had severe swelling before treated, yet the swelling was reduced based on concentration-dependent after receiving caffeic acid. Severe bone loss in AIA rats’ ankle joints were also observed, however the treatment of 125 mg caffeic acid showed remarkable inhibition effect toward rats’ bone loss. Osteoclastogenesis in AIA rats’ ankle joints were higher than the normal ones, as indicated with high TRAP-positive Multinucleated Cells (MNCs). But low number of TRAP-positive MNCs was observed in ankle joint of AIA rats that received 125 mg caffeic acid.

CONCLUSION: Administration of caffeic acid can reduce the degree of swallowing, inhibit bone loss, and inhibit osteoclastogenesis in ankle joint of arthritis-induced rats.

KEYWORDS: caffeic acid, osteoclastogenesis, bone loss, swelling, inflammation, RANKL, TNF-α


Full Text:

PDF

References


Yokota K. Inflammation and osteoclasts. Nihon Rinsho Meneki Gakkai Kaishi. 2017; 40(5): 367-76, CrossRef.

Jones DH, Kong YY, Penninger JM. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis. 2002; 61(Suppl 2): ii32-9, CrossRef.

Izawa T, Hutami IR, Tanaka E. Potential role of rebamipide in osteoclast differentiation and mandibular condylar cartilage homeostasis. Curr Rheumatol Rev. 2018; 14(1): 62-9, CrossRef.

Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med. 2004; 200(7): 941-6, CrossRef.

Ketherin K, Sandra F. Osteoclastogenesis in periodontitis: signaling pathway, synthetic and natural inhibitors. Mol Cell Biomed Sci. 2018; 2(1): 11-8, CrossRef.

Sandra F, Kukita T, Tang QY, Iijima T. Caffeic acid inhibits NFkappaB activation of osteoclastogenesis signaling pathway. Indones Biomed J. 2011; 3(3): 216-22, CrossRef.

Sandra F, Putri J, Limen H, Sarizta B. Caffeic acid inhibits RANKL and TNFa-induced osteoclastogenesis by targeting TAK1-p44/42 MAPK. Indones Biomed J. 2021; 13(4): 433-7, CrossRef.

Caunt CJ, Kiss-Toth E, Carlotti F, Chapman R, Qwarnstrom EE. Ras controls tumor necrosis factor receptor-associated factor (TRAF)6-dependent induction of nuclear factor-κB. J Biol Chem. 2001; 276(9): 6280-8, CrossRef.

Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK, et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature. 2002; 418(6896): 443-7, CrossRef.

Sandra F, Kukita T, Muta T, Iijima T. Caffeic acid inhibited receptor activator of nuclear factor kappaB ligand (RANKL)-tumor necrosis factor (TNF) alpha-TNF receptor associated factor (TRAF) 6 induced osteoclastogenesis pathway. Indones Biomed J. 2013; 5(3): 173-8, CrossRef.

Nelson CA, Warren JT, Wang MWH, Teitelbaum SL, Fremont DH. RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor. Structure. 2012; 20(11): 1971-82, CrossRef.

Tang QY, Kukita T, Ushijima Y, Kukita A, Nagata K, Sandra F, et al. Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats. Histochem Cell Biol. 2006; 125(3): 215-25, CrossRef.

Tapiero H, Tew KD, Nguyen Ba G, Mathé G. Polyphenols: do they play a role in the prevention of human pathologies? Biomed Pharmacother. 2002; 56(4): 200-7, CrossRef.

Sandra F, Sidharta MA. Caffeic acid induced apoptosis in MG63 osteosarcoma cells through activation of caspases. Mol Cell Biomed Sci. 2017; 1(1): 28-33, CrossRef.

Nardini M, Cirillo E, Natella F, Scaccini C. Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem. 2002; 50(20): 5735-41, CrossRef.

Watanabe T, Kukita T, Kukita A, Wada N, Toh K, Nagata K, et al. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol. 2004; 180(1): 193-201, CrossRef.

Zawawi MSF, Perilli E, Stansborough RL, Marino V, Cantley MD, Xu J, et al. Caffeic acid phenethyl ester abrogates bone resorption in a murine calvarial model of polyethylene particle-induced osteolysis. Calcif Tissue Int. 2015; 96(6): 565-74, CrossRef.

Chillingworth NL, Donaldson LF. Characterisation of a Freund’s complete adjuvant-induced model of chronic arthritis in mice. J Neurosci Methods. 2003; 128(1-2): 45-52, CrossRef.

Noh ASM, Chuan TD, Khir NAM, Zin AAM, Ghazali AK, Long I, et al. Effects of different doses of complete Freund’s adjuvant on nociceptive behaviour and inflammatory parameters in polyarthritic rat model mimicking rheumatoid arthritis. PLoS ONE. 2021; 16(12): e0260423, CrossRef.

Williams B, Tsangari E, Stansborough R, Marino V, Cantley M, Dharmapatni A, et al. Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis. Inflammopharmacol. 2017; 25(1): 55-68, CrossRef.

Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-α–mediated joint destruction. J Clin Invest. 2002; 110(10): 1419-27, CrossRef.

Sandra F, Briskila J, Ketherin K. RANKL and TNF-a-induced JNK/SAPK osteoclastogenic signaling pathway was inhibited by caffeic acid in RAW-D cells. Indones J Cancer Chemoprev. 2018; 9(2): 63-7, CrossRef.

Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008; 473(2): 139-46, CrossRef.




DOI: https://doi.org/10.18585/inabj.v14i3.2033

 

Indexed by:

                  

               

                 

 

 

The Prodia Education and Research Institute